Blood-borne RNA correlates with disease activity and ifn-stimulated gene expression in systemic lupus erythematosus

Journal of Immunology

Volumn 197, Issue 7, 2016, Pages 2854-2863

  Doedens, John R ^a   Jones, Wendell D ^b   Hill, Kay ^c   Mason, Michael J ^d   Gersuk, Vivian H ^e   Mease, Philip J ^f   Dall'era, Maria ^g   Aranow, Cynthia ^h   Martin, Richard W ⁱ   Cohen, Stanley B ^j   Fleischmann, Roy M ^j   Kivitz, Alan J ^k   Burge, Daniel J ^l   Chaussabel, Damien ^a   Elkon, Keith B ^e,f   Posada, James A ^a  

^a Resolve TherapeuticsLLC   (United States)

^b EA Genomics Q2 Solutions   (United States)

^c Everett   (United States)

^d SAGE BIONETWORKS   (United States)

^e BENAROYA RESEARCH INSTITUTE   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

ⁱ MICHIGAN STATE UNIVERSITY   (United States)

^j METROPLEX CLINICAL RESEARCH CENTER   (United States)

^k Altoona Center for Clinical Research   (United States)

^l SIDRA MEDICAL AND RESEARCH CENTER   (Qatar)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; INTERFERON; UNTRANSLATED RNA; RNA; SMALL CYTOPLASMIC RNA; SMALL NUCLEAR RNA; U1 SMALL NUCLEAR RNA;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIGEN ANTIBODY COMPLEX; ANTIGEN BINDING; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; GENE; GENE EXPRESSION; GENE FUNCTION; HUMAN; HUMAN CELL; IFN GENE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RNA ANALYSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; ANTIGEN ANTIBODY REACTION; BLOOD; CASE CONTROL STUDY; CROSS-SECTIONAL STUDY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; MIDDLE AGED;

ADULT; ANTIGEN-ANTIBODY REACTIONS; AUTOANTIBODIES; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INTERFERONS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; RNA; RNA, SMALL CYTOPLASMIC; RNA, SMALL NUCLEAR;

EID: 84989859132     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1601142     Document Type: Article

References (59)

1. Tsokos, G. C. 2011. Systemic lupus erythematosus. N. Engl. J. Med. 365: 2110- 2121.
2. Solomon, D. H., A. J. Kavanaugh, and P. H. Schur, American College of Rheumatology Ad Hoc Committee on Immunologic Testing Guidelines. 2002. Evidence-based guidelines for the use of immunologic tests: Antinuclear antibody testing. Arthritis Rheum. 47: 434-444.
3. Moder, K. G., M. H. Wener, M. H. Weisman, M. L. Ishimori, D. J. Wallace, D. L. Buckeridge, and H. A. Homburger. 2007. Measurement of antinuclear antibodies by multiplex immunoassay: A prospective, multicenter clinical evaluation. J. Rheumatol. 34: 978-986.
4. Rose, L. M., D. S. Latchman, and D. A. Isenberg. 1997. Apoptosis in peripheral lymphocytes in systemic lupus erythematosus: A review. Br. J. Rheumatol. 36: 158-163.
5. Poon, I. K., C. D. Lucas, A. G. Rossi, and K. S. Ravichandran. 2014. Apoptotic cell clearance: basic biology and therapeutic potential. Nat. Rev. Immunol. 14: 166-180.
6. Mahajan, A., M. Herrmann, and L. E. Muñoz. 2016. Clearance deficiency and cell death pathways: A model for the pathogenesis of SLE. Front. Immunol. 7: 35.
7. Liu, Z., and A. Davidson. 2012. Taming lupus-A new understanding of pathogenesis is leading to clinical advances. Nat. Med. 18: 871-882.
8. To, C. H., and M. Petri. 2005. Is antibody clustering predictive of clinical subsets and damage in systemic lupus erythematosus? Arthritis Rheum. 52: 4003-4010.
9. Kirou, K. A., C. Lee, S. George, K. Louca, M. G. Peterson, and M. K. Crow. 2005. Activation of the interferon-A pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease. Arthritis Rheum. 52: 1491-1503.
10. Li, P. H., W. H. Wong, T. L. Lee, C. S. Lau, T. M. Chan, A. M. Leung, K. L. Tong, N. K. C. Tse, C. C. Mok, S. N. Wong, et al. 2013. Relationship between autoantibody clustering and clinical subsets in SLE: cluster and association analyses in Hong Kong Chinese. Rheumatology (Oxford) 52: 337-345.
11. Baechler, E. C., F. M. Batliwalla, G. Karypis, P. M. Gaffney, W. A. Ortmann, K. J. Espe, K. B. Shark, W. J. Grande, K. M. Hughes, V. Kapur, et al. 2003. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc. Natl. Acad. Sci. USA 100: 2610-2615.
12. Chaussabel, D., C. Quinn, J. Shen, P. Patel, C. Glaser, N. Baldwin, D. Stichweh, D. Blankenship, L. Li, I. Munagala, et al. 2008. A modular analysis framework for blood genomics studies: Application to systemic lupus erythematosus. Immunity 29: 150-164.
13. Arasappan, D., W. Tong, P. Mummaneni, H. Fang, and S. Amur. 2011. Metaanalysis of microarray data using a pathway-based approach identifies a 37-gene expression signature for systemic lupus erythematosus in human peripheral blood mononuclear cells. BMC Med. 9: 65.
14. Chiche, L., N. Jourde-Chiche, E. Whalen, S. Presnell, V. Gersuk, K. Dang, E. Anguiano, C. Quinn, S. Burtey, Y. Berland, et al. 2014. Modular transcriptional repertoire analyses of adults with systemic lupus erythematosus reveal distinct type I and type II interferon signatures. Arthritis Rheumatol. 66: 1583- 1595.
15. Hall, J. C., and A. Rosen. 2010. Type I interferons: crucial participants in disease amplification in autoimmunity. Nat. Rev. Rheumatol. 6: 40-49.
16. Theofilopoulos, A. N., R. Gonzalez-Quintial, B. R. Lawson, Y. T. Koh, M. E. Stern, D. H. Kono, B. Beutler, and R. Baccala. 2010. Sensors of the innate immune system: Their link to rheumatic diseases. Nat. Rev. Rheumatol. 6: 146- 156.
17. Barrat, F. J., K. B. Elkon, and K. A. Fitzgerald. 2016. Importance of nucleic acid recognition in inflammation and autoimmunity. Annu. Rev. Med. 67: 323-336.
18. Fairhurst, A. M., S. H. Hwang, A. Wang, X. H. Tian, C. Boudreaux, X. J. Zhou, J. Casco, Q. Z. Li, J. E. Connolly, and E. K. Wakeland. 2008. Yaa autoimmune phenotypes are conferred by overexpression of TLR7. Eur. J. Immunol. 38: 1971-1978.
19. Deane, J. A., P. Pisitkun, R. S. Barrett, L. Feigenbaum, T. Town, J. W. Ward, R. A. Flavell, and S. Bolland. 2007. Control of toll-like receptor 7 expression is essential to restrict autoimmunity and dendritic cell expansion. Immunity 27: 801-810.
20. Lee, Y. H., H. S. Lee, S. J. Choi, J. D. Ji, and G. G. Song. 2012. Associations between TLR polymorphisms and systemic lupus erythematosus: A systematic review and meta-Analysis. Clin. Exp. Rheumatol. 30: 262-265.
21. Garcia-Romo, G. S., S. Caielli, B. Vega, J. Connolly, F. Allantaz, Z. Xu, M. Punaro, J. Baisch, C. Guiducci, R. L. Coffman, et al. 2011. Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Sci. Transl. Med. 3: 73ra20.
22. Kono, D. H., M. K. Haraldsson, B. R. Lawson, K. M. Pollard, Y. T. Koh, X. Du, C. N. Arnold, R. Baccala, G. J. Silverman, B. A. Beutler, and A. N. Theofilopoulos. 2009. Endosomal TLR signaling is required for antinucleic acid and rheumatoid factor autoantibodies in lupus. Proc. Natl. Acad. Sci. USA 106: 12061-12066.
23. Leadbetter, E. A., I. R. Rifkin, A. M. Hohlbaum, B. C. Beaudette, M. J. Shlomchik, and A. Marshak-Rothstein. 2002. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416: 603-607.
24. Lau, C. M., C. Broughton, A. S. Tabor, S. Akira, R. A. Flavell, M. J. Mamula, S. R. Christensen, M. J. Shlomchik, G. A. Viglianti, I. R. Rifkin, and A. Marshak-Rothstein. 2005. RNA-Associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement. J. Exp. Med. 202: 1171-1177.
25. Kelly, K. M., H. Zhuang, D. C. Nacionales, P. O. Scumpia, R. Lyons, J. Akaogi, P. Lee, B. Williams, M. Yamamoto, S. Akira, et al. 2006. "Endogenous adjuvant" activity of the RNA components of lupus autoantigens Sm/RNP and Ro 60. Arthritis Rheum. 54: 1557-1567.
26. Lövgren, T., M.-L. Eloranta, B. Kastner, M. Wahren-Herlenius, G. V. Alm, and L. Rönnblom. 2006. Induction of interferon-A by immune complexes or liposomes containing systemic lupus erythematosus autoantigen-And Sjögren's syndrome autoantigen-Associated RNA. Arthritis Rheum. 54: 1917-1927.
27. Eloranta, M.-L., T. Lövgren, D. Finke, L. Mathsson, J. Rönnelid, B. Kastner, G. V. Alm, and L. Rönnblom. 2009. Regulation of the interferon-A production induced by RNA-containing immune complexes in plasmacytoid dendritic cells. Arthritis Rheum. 60: 2418-2427.
28. van der Feltz, C., K. Anthony, A. Brilot, and D. A. Pomeranz Krummel. 2012. Architecture of the spliceosome. Biochemistry 51: 3321-3333.
29. Stark, H., P. Dube, R. Luhrmann, and B. Kastner. 2001. Arrangement of RNA and proteins in the spliceosomal U1 small nuclear ribonucleoprotein particle. Nature 409: 539-542.
30. Means, T. K., E. Latz, F. Hayashi, M. R. Murali, D. T. Golenbock, and A. D. Luster. 2005. Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9. J. Clin. Invest. 115: 407-417.
31. Erdei, A., A. Isaák, K. Török, N. Sándor, M. Kremlitzka, J. Prechl, and Z. Bajtay. 2009. Expression and role of CR1 and CR2 on B and T lymphocytes under physiological and autoimmune conditions. Mol. Immunol. 46: 2767-2773.
32. Bave, U., G. V. Alm, and L. Rönnblom. 2000. The combination of apoptotic U937 cells and lupus IgG is a potent IFN-Alpha inducer. J. Immunol. 165: 3519- 3526.
33. Lövgren, T., M.-L. Eloranta, U. Bave, G. V. Alm, and L. Rönnblom. 2004. Induction of interferon-Alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG. Arthritis Rheum. 50: 1861-1872.
34. Shin, M. S., Y. Kang, N. Lee, S. H. Kim, K. S. Kang, R. Lazova, and I. Kang. 2012. U1-small nuclear ribonucleoprotein activates the NLRP3 inflammasome in human monocytes. J. Immunol. 188: 4769-4775.
35. Lood, C., M. Allhorn, R. Lood, B. Gullstrand, A. I. Olin, L. Rönnblom, L. Truedsson, M. Collin, and A. A. Bengtsson. 2012. IgG glycan hydrolysis by endoglycosidase S diminishes the proinflammatory properties of immune complexes from patients with systemic lupus erythematosus: A possible new treatment? Arthritis Rheum. 64: 2698-2706.
36. Lood, C., L. P. Blanco, M. M. Purmalek, C. Carmona-Rivera, S. S. De Ravin, C. K. Smith, H. L. Malech, J. A. Ledbetter, K. B. Elkon, and M. J. Kaplan. 2016. Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease. Nat. Med. 22: 146-153.
37. Theofilopoulos, A. N., C. B. Wilson, and F. J. Dixon. 1976. The Raji cell radioimmune assay for detecting immune complexes in human sera. J. Clin. Invest. 57: 169-182.
38. Ahlin, E., L. Mathsson, M. L. Eloranta, T. Jonsdottir, I. Gunnarsson, L. Rönnblom, and J. Rönnelid. 2012. Autoantibodies associated with RNA are more enriched than anti-dsDNA antibodies in circulating immune complexes in SLE. Lupus 21: 586-595.
39. Nezlin, R., D. Alarcón-Segovia, and Y. Shoenfeld. 1998. Immunochemical determination of DNA in immune complexes present in the circulation of patients with systemic lupus erythematosus. J. Autoimmun. 11: 489-493.
40. Petri, M., J. Buyon, and M. Kim. 1999. Classification and definition of major flares in SLE clinical trials. Lupus 8: 685-691.
41. Weickmann, J. L., and D. G. Glitz. 1982. Human ribonucleases. Quantitation of pancreatic-like enzymes in serum, urine, and organ preparations. J. Biol. Chem. 257: 8705-8710.
42. Allantaz, F., D. Chaussabel, D. Stichweh, L. Bennett, W. Allman, A. Mejias, M. Ardura, W. Chung, E. Smith, C. Wise, et al. 2007. Blood leukocyte microarrays to diagnose systemic onset juvenile idiopathic arthritis and follow the response to IL-1 blockade. [Published erratum appears in 2009 J. Exp. Med. 206: 2299.] J. Exp. Med. 204: 2131-2144.
43. Berry, M. P., C. M. Graham, F. W. McNab, Z. Xu, S. A. Bloch, T. Oni, K. A. Wilkinson, R. Banchereau, J. Skinner, R. J. Wilkinson, et al. 2010. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 466: 973-977.
44. Park, J., I. Munagala, H. Xu, D. Blankenship, P. Maffucci, D. Chaussabel, J. Banchereau, V. Pascual, and C. Cunningham-Rundles. 2013. Interferon signature in the blood in inflammatory common variable immune deficiency. PLoS One 8: e74893.
45. Kennedy, W. P., R. Maciuca, K. Wolslegel, W. Tew, A. R. Abbas, C. Chaivorapol, A. Morimoto, J. M. McBride, P. Brunetta, B. C. Richardson, et al. 2015. Association of the interferon signature metric with serological disease manifestations but not global activity scores in multiple cohorts of patients with SLE. Lupus Sci. Med. 2: e000080.
46. Slobbe, R. L., W. Pluk, W. J. van Venrooij, and G. J. Pruijn. 1992. Ro ribonucleoprotein assembly in vitro. Identification of RNA-protein and protein-protein interactions. J. Mol. Biol. 227: 361-366.
47. Hung, T., G. A. Pratt, B. Sundararaman, M. J. Townsend, C. Chaivorapol, T. Bhangale, R. R. Graham, W. Ortmann, L. A. Criswell, G. W. Yeo, and T. W. Behrens. 2015. The Ro60 autoantigen binds endogenous retroelements and regulates inflammatory gene expression. Science 350: 455-459.
48. Klein Gunnewiek, J. M., L. B. van de Putte, and W. J. van Venrooij. 1997. The U1 snRNP complex: An autoantigen in connective tissue diseases. An update. Clin. Exp. Rheumatol. 15: 549-560.
49. Hoet, R. M., P. De Weerd, J. K. Gunnewiek, I. Koornneef, and W. J. Van Venrooij. 1992. Epitope regions on U1 small nuclear RNA recognized by anti-U1RNAspecific autoantibodies. J. Clin. Invest. 90: 1753-1762.
50. Sherer, Y., A. Gorstein, M. J. Fritzler, and Y. Shoenfeld. 2004. Autoantibody explosion in systemic lupus erythematosus: more than 100 different antibodies found in SLE patients. Semin. Arthritis Rheum. 34: 501-537.
51. Maddison, P. J., and M. Reichlin. 1977. Quantitation of precipitating antibodies to certain soluble nuclear antigens in SLE. Arthritis Rheum. 20: 819-824.
52. Buyon, J. P., P. Cohen, J. T. Merrill, G. Gilkeson, M. Kaplan, J. James, W. J. McCune, S. Bernatsky, and K. Elkon. 2015. A highlight from the LUPUS 2014 meeting: eight great ideas. Lupus Sci. Med. 2: e000087.
53. Hieronymus, T., P. Grötsch, N. Blank, M. Grunke, D. Capraru, T. Geiler, S. Winkler, J. R. Kalden, and H. M. Lorenz. 2000. Chlorpromazine induces apoptosis in activated human lymphoblasts: A mechanism supporting the induction of drug-induced lupus erythematosus? Arthritis Rheum. 43: 1994-2004.
54. Achtman, J. C., and V. P. Werth. 2015. Pathophysiology of cutaneous lupus erythematosus. Arthritis Res. Ther. 17: 182.
55. Edberg, J. C., G. A. Kujala, and R. P. Taylor. 1987. Rapid immune adherence reactivity of nascent, soluble antibody/DNA immune complexes in the circulation. J. Immunol. 139: 1240-1244.
56. Davies, K. A., V. Hird, S. Stewart, G. B. Sivolapenko, P. Jose, A. A. Epenetos, and M. J. Walport. 1990. A study of in vivo immune complex formation and clearance in man. J. Immunol. 144: 4613-4620.
57. Davies, K. A., A. M. Peters, H. L. Beynon, and M. J. Walport. 1992. Immune complex processing in patients with systemic lupus erythematosus. In vivo imaging and clearance studies. J. Clin. Invest. 90: 2075-2083.
58. Tan, E. M., T. E. Feltkamp, J. S. Smolen, B. Butcher, R. Dawkins, M. J. Fritzler, T. Gordon, J. A. Hardin, J. R. Kalden, R. G. Lahita, et al. 1997. Range of antinuclear antibodies in "healthy" individuals. Arthritis Rheum. 40: 1601-1611.
59. Giannouli, E., D. Chatzidimitriou, S. Gerou, E. Gavriilaki, L. Settas, and E. Diza. 2013. Frequency and specificity of antibodies against nuclear and cytoplasmic antigens in healthy individuals by classic and new methods. Clin. Rheumatol. 32: 1541-1546.